The Liver and Kidneys mediate clearance of cardiac troponin in the rat.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
22 04 2020
22 04 2020
Historique:
received:
18
11
2019
accepted:
27
03
2020
entrez:
24
4
2020
pubmed:
24
4
2020
medline:
1
12
2020
Statut:
epublish
Résumé
Cardiac-specific troponins (cTn), troponin T (cTnT) and troponin I (cTnI) are diagnostic biomarkers when myocardial infarction is suspected. Despite its clinical importance it is still not known how cTn is cleared once it is released from damaged cardiac cells. The aim of this study was to examine the clearance of cTn in the rat. A cTn preparation from pig heart was labeled with fluorescent dye or fluorine 18 (
Identifiants
pubmed: 32322013
doi: 10.1038/s41598-020-63744-8
pii: 10.1038/s41598-020-63744-8
pmc: PMC7176693
doi:
Substances chimiques
Fluorescent Dyes
0
Fluorine Radioisotopes
0
Troponin T
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
6791Références
Filatov, V. L., Katrukha, A. G., Bulargina, T. V. & Gusev, N. B. Troponin: structure, properties, and mechanism of functioning. Biochemistry (Mosc) 64, 969–985 (1999).
Starnberg, K. et al. A Possible Mechanism behind Faster Clearance and Higher Peak Concentrations of Cardiac Troponin I Compared with Troponin T in Acute Myocardial Infarction. Clin Chem 66, 333–341, https://doi.org/10.1093/clinchem/hvz003 (2020).
doi: 10.1093/clinchem/hvz003
pubmed: 32040581
Roffi, M. et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J 37, 267–315, https://doi.org/10.1093/eurheartj/ehv320 (2016).
doi: 10.1093/eurheartj/ehv320
pubmed: 26320110
Bandstein, N., Ljung, R., Johansson, M. & Holzmann, M. J. Undetectable high-sensitivity cardiac troponin T level in the emergency department and risk of myocardial infarction. J Am Coll Cardiol 63, 2569–2578, https://doi.org/10.1016/j.jacc.2014.03.017 (2014).
doi: 10.1016/j.jacc.2014.03.017
pubmed: 24694529
Reichlin, T. et al. Prospective validation of a 1-hour algorithm to rule-out and rule-in acute myocardial infarction using a high-sensitivity cardiac troponin T assay. CMAJ 187, E243–252, https://doi.org/10.1503/cmaj.141349 (2015).
doi: 10.1503/cmaj.141349
pubmed: 25869867
pmcid: 4435896
Bjurman, C. et al. Decreased admissions and hospital costs with a neutral effect on mortality following lowering of the troponin T cutoff point to the 99th percentile. Cardiol J, https://doi.org/10.5603/CJ.a2017.0079 (2017).
Hammarsten, O. et al. Troponin T percentiles from a random population sample, emergency room patients and patients with myocardial infarction. Clin Chem 58, 628–637, https://doi.org/10.1373/clinchem.2011.171496 (2012).
doi: 10.1373/clinchem.2011.171496
pubmed: 22258764
Hammarsten, O., Theodorsson, E., Bjurman, C. & Petzold, M. Risk of myocardial infarction at specific troponin T levels using the parameter predictive value among lookalikes (PAL). Clinical biochemistry, https://doi.org/10.1016/j.clinbiochem.2016.09.012 (2016).
Bjurman, C. et al. Small changes in troponin T levels are common in patients with non-ST-segment elevation myocardial infarction and are linked to higher mortality. J Am Coll Cardiol 62, 1231–1238, https://doi.org/10.1016/j.jacc.2013.06.050 (2013).
doi: 10.1016/j.jacc.2013.06.050
pubmed: 23933541
Carlsson, A. C., Bandstein, N., Roos, A., Hammarsten, O. & Holzmann, M. J. High-sensitivity cardiac troponin T levels in the emergency department in patients with chest pain but no myocardial infarction. Int J Cardiol 228, 253–259, https://doi.org/10.1016/j.ijcard.2016.11.087 (2017).
doi: 10.1016/j.ijcard.2016.11.087
pubmed: 27865194
Chapman, A. R. et al. Association of High-Sensitivity Cardiac Troponin I Concentration With Cardiac Outcomes in Patients With Suspected Acute Coronary Syndrome. JAMA 318, 1913–1924, https://doi.org/10.1001/jama.2017.17488 (2017).
doi: 10.1001/jama.2017.17488
pubmed: 29127948
pmcid: 5710293
Lee, K. K. et al. Prevalence, Determinants, and Clinical Associations of High-Sensitivity Cardiac Troponin in Patients Attending Emergency Departments. Am J Med 132, 110 e118–110 e121, https://doi.org/10.1016/j.amjmed.2018.10.002 (2019).
doi: 10.1016/j.amjmed.2018.10.002
Stelzle, D. et al. High-sensitivity cardiac troponin I and risk of heart failure in patients with suspected acute coronary syndrome: a cohort study. Eur Heart J Qual Care Clin Outcomes 4, 36–42, https://doi.org/10.1093/ehjqcco/qcx022 (2018).
doi: 10.1093/ehjqcco/qcx022
pubmed: 29045610
Roos, A. et al. Stable High-Sensitivity Cardiac Troponin T Levels and Outcomes in Patients With Chest Pain. J Am Coll Cardiol 70, 2226–2236, https://doi.org/10.1016/j.jacc.2017.08.064 (2017).
doi: 10.1016/j.jacc.2017.08.064
pubmed: 29073949
Nordenskjold, A. M. et al. Short- and long-term individual variation in cardiac troponin in patients with stable coronary artery disease. Clin Chem 59, 401–409, https://doi.org/10.1373/clinchem.2012.191700 (2013).
doi: 10.1373/clinchem.2012.191700
pubmed: 23143329
Hammarsten, O., Mair, J., Mockel, M., Lindahl, B. & Jaffe, A. S. Possible mechanisms behind cardiac troponin elevations. Biomarkers, 1-10, https://doi.org/10.1080/1354750X.2018.1490969 (2018).
Andersson, H. et al. Assaying cardiac biomarkers for toxicity testing using biosensing and cardiomyocytes derived from human embryonic stem cells. J Biotechnol 150, 175–181, https://doi.org/10.1016/j.jbiotec.2010.06.023 (2010).
doi: 10.1016/j.jbiotec.2010.06.023
pubmed: 20633583
Bjurman, C. et al. High-sensitive cardiac troponin, NT-proBNP, hFABP and copeptin levels in relation to glomerular filtration rates and a medical record of cardiovascular disease. Clin Biochem 48, 302–307, https://doi.org/10.1016/j.clinbiochem.2015.01.008 (2015).
doi: 10.1016/j.clinbiochem.2015.01.008
pubmed: 25637776
Miller-Hodges, E. et al. High-Sensitivity Cardiac Troponin and the Risk Stratification of Patients With Renal Impairment Presenting With Suspected Acute Coronary Syndrome. Circulation 137, 425–435, https://doi.org/10.1161/CIRCULATIONAHA.117.030320 (2018).
doi: 10.1161/CIRCULATIONAHA.117.030320
pubmed: 28978551
pmcid: 5793996
Friden, V. et al. Clearance of cardiac troponin T with and without kidney function. Clin Biochem 50, 468–474, https://doi.org/10.1016/j.clinbiochem.2017.02.007 (2017).
doi: 10.1016/j.clinbiochem.2017.02.007
pubmed: 28193484
Kashioulis, P. et al. High-NaCl Diet Aggravates Cardiac Injury in Rats with Adenine-Induced Chronic Renal Failure and Increases Serum Troponin T Levels. Cardiorenal Med 6, 317–327, https://doi.org/10.1159/000446547 (2016).
doi: 10.1159/000446547
pubmed: 27648013
pmcid: 5020396
Potter, J. D. Preparation of troponin and its subunits. Methods Enzymol 85 Pt B, 241–263, https://doi.org/10.1016/0076-6879(82)85024-6 (1982).
doi: 10.1016/0076-6879(82)85024-6
pubmed: 7121270
Michielsen, E. C., Diris, J. H., Kleijnen, V. W., Wodzig, W. K. & Van Dieijen-Visser, M. P. Interpretation of cardiac troponin T behaviour in size-exclusion chromatography. Clin Chem Lab Med 44, 1422–1427, https://doi.org/10.1515/CCLM.2006.265 (2006).
doi: 10.1515/CCLM.2006.265
pubmed: 17163817
Luciano, T. F. et al. Responses of skeletal muscle hypertrophy in Wistar rats to different resistance exercise models. Physiol Res 66, 317–323 (2017).
doi: 10.33549/physiolres.933256
Piao, Y., Liu, Y. & Xie, X. Change trends of organ weight background data in sprague dawley rats at different ages. J Toxicol Pathol 26, 29–34, https://doi.org/10.1293/tox.26.29 (2013).
doi: 10.1293/tox.26.29
pubmed: 23723565
pmcid: 3620211
Schoeffner, D. J., Warren, D. A., Muralidara, S., Bruckner, J. V. & Simmons, J. E. Organ weights and fat volume in rats as a function of strain and age. J Toxicol Environ Health A 56, 449–462, https://doi.org/10.1080/009841099157917 (1999).
doi: 10.1080/009841099157917
pubmed: 10201633
Olberg, D. E. et al. One step radiosynthesis of 6-[(18)F]fluoronicotinic acid 2,3,5,6-tetrafluorophenyl ester ([(18)F]F-Py-TFP): a new prosthetic group for efficient labeling of biomolecules with fluorine-18. J Med Chem 53, 1732–1740, https://doi.org/10.1021/jm9015813 (2010).
doi: 10.1021/jm9015813
pubmed: 20088512
Hammarsten, O., Jacobsson, C.-E., Widegren, M. & Jaffe, A. S. Long-time quality assessment of the Elecsys Troponin T hs assay. Clinical Biochemistry (in press) (2013).
Smit, M. J., Duursma, A. M., Bouma, J. M. & Gruber, M. Receptor-mediated endocytosis of lactate dehydrogenase M4 by liver macrophages: a mechanism for elimination of enzymes from plasma. Evidence for competition by creatine kinase MM, adenylate kinase, malate, and alcohol dehydrogenase. J Biol Chem 262, 13020–13026 (1987).
pubmed: 2820961
Maxwell, J. L., Terracio, L., Borg, T. K., Baynes, J. W. & Thorpe, S. R. A fluorescent residualizing label for studies on protein uptake and catabolism in vivo and in vitro. Biochem J 267, 155–162, https://doi.org/10.1042/bj2670155 (1990).
doi: 10.1042/bj2670155
pubmed: 1691636
pmcid: 1131258
Qian, Z. M., Li, H., Sun, H. & Ho, K. Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway. Pharmacol Rev 54, 561–587, https://doi.org/10.1124/pr.54.4.561 (2002).
doi: 10.1124/pr.54.4.561
pubmed: 12429868
Ashwell, G. & Harford, J. Carbohydrate-specific receptors of the liver. Annu Rev Biochem 51, 531–554, https://doi.org/10.1146/annurev.bi.51.070182.002531 (1982).
doi: 10.1146/annurev.bi.51.070182.002531
pubmed: 6287920
Steirer, L. M., Park, E. I., Townsend, R. R. & Baenziger, J. U. The asialoglycoprotein receptor regulates levels of plasma glycoproteins terminating with sialic acid alpha2,6-galactose. J Biol Chem 284, 3777-3783, doi:10.1074/jbc.M808689200 (2009).
Morell, A. G., Irvine, R. A., Sternlieb, I., Scheinberg, I. H. & Ashwell, G. Physical and chemical studies on ceruloplasmin. V. Metabolic studies on sialic acid-free ceruloplasmin in vivo. J Biol Chem 243, 155–159 (1968).
pubmed: 5635941
Amako, T., Koga, J., Kobayashi, A., Urakado, S. & Tokunaga, J. Experimental Investigation of the Metabolism of Myoglobin. Kyushu J Med Sci 14, 277–287 (1963).
pubmed: 14104467
Bywaters, E. G. & Beall, D. Crush injuries with impairment of renal function. 1941. J Am Soc Nephrol 9, 322–332 (1998).
pubmed: 9527411
Hayashi, T. & Notkins, A. L. Clearance of LDH-5 from the circulation of inbred mice correlates with binding to macrophages. Int J Exp Pathol 75, 165–168 (1994).
pubmed: 8086313
pmcid: 2001804
Hayashi, T., Salata, K., Kingman, A. & Notkins, A. L. Regulation of enzyme levels in the blood. Influence of environmental and genetic factors on enzyme clearance. Am J Pathol 132, 503–511 (1988).
pubmed: 2843049
pmcid: 1880744
Radi, Z. A. et al. Increased serum enzyme levels associated with kupffer cell reduction with no signs of hepatic or skeletal muscle injury. Am J Pathol 179, 240–247, https://doi.org/10.1016/j.ajpath.2011.03.029 (2011).
doi: 10.1016/j.ajpath.2011.03.029
pubmed: 21703406
pmcid: 3123844
Prabhudas, M. et al. Standardizing scavenger receptor nomenclature. J Immunol 192, 1997–2006, https://doi.org/10.4049/jimmunol.1490003 (2014).
doi: 10.4049/jimmunol.1490003
pubmed: 24563502
pmcid: 4238968
Tenstad, O., Williamson, H. E., Clausen, G., Oien, A. H. & Aukland, K. Glomerular filtration and tubular absorption of the basic polypeptide aprotinin. Acta Physiol Scand 152, 33–50, https://doi.org/10.1111/j.1748-1716.1994.tb09782.x (1994).
doi: 10.1111/j.1748-1716.1994.tb09782.x
pubmed: 7528967
Tenstad, O., Roald, A. B., Grubb, A. & Aukland, K. Renal handling of radiolabelled human cystatin C in the rat. Scand J Clin Lab Invest 56, 409–414, https://doi.org/10.3109/00365519609088795 (1996).
doi: 10.3109/00365519609088795
pubmed: 8869663
Ziebig, R. et al. Renal elimination of troponin T and troponin I. Clin Chem 49, 1191–1193, https://doi.org/10.1373/49.7.1191 (2003).
doi: 10.1373/49.7.1191
pubmed: 12816921
Boneu, B., Caranobe, C. & Sie, P. Pharmacokinetics of heparin and low molecular weight heparin. Baillieres Clin Haematol 3, 531–544 (1990).
doi: 10.1016/S0950-3536(05)80017-4
Mekontso Dessap, A. et al. Effect of renal failure on peak troponin Ic level in patients with acute myocardial infarction. Cardiology 109, 217–221, https://doi.org/10.1159/000107783 (2008).
doi: 10.1159/000107783
pubmed: 17873484
Ellis, K., Dreisbach, A. W. & Lertora, J. L. Plasma elimination of cardiac troponin I in end-stage renal disease. South Med J 94, 993–996, https://doi.org/10.1097/00007611-200194100-00011 (2001).
doi: 10.1097/00007611-200194100-00011
pubmed: 11702827
Apple, F. S., Murakami, M. M., Pearce, L. A. & Herzog, C. A. Multi-biomarker risk stratification of N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and cardiac troponin T and I in end-stage renal disease for all-cause death. Clin Chem 50, 2279–2285, https://doi.org/10.1373/clinchem.2004.035741 (2004).
doi: 10.1373/clinchem.2004.035741
pubmed: 15364888
Mockel, M. et al. Prognostic value of cardiac troponin T and I elevations in renal disease patients without acute coronary syndromes: a 9-month outcome analysis. Nephrol Dial Transplant 14, 1489–1495, https://doi.org/10.1093/ndt/14.6.1489 (1999).
doi: 10.1093/ndt/14.6.1489
pubmed: 10383013
Sylven, C. The kinetics of myoglobin in old volunteers and in patients with acute myocardial infarction. Scand J Clin Lab Invest 38, 561–565, https://doi.org/10.1080/00365517809108820 (1978).
doi: 10.1080/00365517809108820
pubmed: 705239
Hallgren, R., Karlsson, F. A., Roxin, L. E. & Venge, P. Myoglobin turnover-influence of renal and extrarenal factors. J Lab Clin Med 91, 246–254 (1978).
pubmed: 340602
Wiessner, R. et al. Impact of kidney function on plasma troponin concentrations after coronary artery bypass grafting. Nephrol Dial Transplant 23, 231–238, https://doi.org/10.1093/ndt/gfm513 (2008).
doi: 10.1093/ndt/gfm513
pubmed: 17898023
Parekh, N. K., Hynan, L. S., De Lemos, J., Lee, W. M. & Acute Liver Failure Study, G. Elevated troponin I levels in acute liver failure: is myocardial injury an integral part of acute liver failure? Hepatology 45, 1489–1495, https://doi.org/10.1002/hep.21640 (2007).
doi: 10.1002/hep.21640
pubmed: 17538968
Katus, H. A., Remppis, A., Scheffold, T., Diederich, K. W. & Kuebler, W. Intracellular compartmentation of cardiac troponin T and its release kinetics in patients with reperfused and nonreperfused myocardial infarction. Am J Cardiol 67, 1360–1367 (1991).
doi: 10.1016/0002-9149(91)90466-X
Frobert, A. et al. Prognostic Value of Troponin I for Infarct Size to Improve Preclinical Myocardial Infarction Small Animal Models. Front Physiol 6, 353, https://doi.org/10.3389/fphys.2015.00353 (2015).
doi: 10.3389/fphys.2015.00353
pubmed: 26640441
pmcid: 4661277
Starnberg, K., Jeppsson, A., Lindahl, B., Berggren, K. & Hammarsten, O. Revision of the troponin T release mechanism from a damaged human myocardium. Clinical Chemistry 60, 1098–1104, https://doi.org/10.1373/clinchem.2013.217943. (2014).
doi: 10.1373/clinchem.2013.217943.
pubmed: 24842954
Streng, A. S. et al. Identification and Characterization of Cardiac Troponin T Fragments in Serum of Patients Suffering from Acute Myocardial Infarction. Clin Chem 63, 563–572, https://doi.org/10.1373/clinchem.2016.261511 (2017).
doi: 10.1373/clinchem.2016.261511
pubmed: 27940450